Literature DB >> 1969789

Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.

P Devilee1, C J Cornelisse, N Kuipers-Dijkshoorn, C Jonker, P L Pearson.   

Abstract

The marker D17S5, mapping to the short arm of chromosome 17, was recently reported by us and others to undergo frequent heterozygous deletion in human primary breast carcinomas, implicating the presence of a tumor suppressor gene in this region. To narrow down the location of this gene more precisely, we have performed a deletion-mapping study in an extended series of 78 breast carcinomas, using nine polymorphic markers for the short arm and two polymorphic markers for the long arm of chromosome 17. Partial allele losses on 17p were observed in nine cases, which, taken together, suggest that the target gene for the deletions maps to the region extending between the markers D17S5 (17p13.3) and D17S67 (17p12).

Entities:  

Mesh:

Year:  1990        PMID: 1969789     DOI: 10.1159/000132893

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  10 in total

1.  Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.

Authors:  L C Chen; A Neubauer; W Kurisu; F M Waldman; B M Ljung; W Goodson; E S Goldman; D Moore; M Balazs; E Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 2.  Molecular genetic studies of early breast cancer evolution.

Authors:  P O'Connell; V Pekkel; S Fuqua; C K Osborne; D C Allred
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 3.  Binding of pro-prion to filamin A: by design or an unfortunate blunder.

Authors:  C Li; W Xin; M-S Sy
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

Review 4.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

5.  Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.

Authors:  A L Børresen; E Hovig; B Smith-Sørensen; D Malkin; S Lystad; T I Andersen; J M Nesland; K J Isselbacher; S H Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds.

Authors:  P Devilee; R S Cornelis; A Bootsma; A Bardoel; M van Vliet; I van Leeuwen; F J Cleton; A de Klein; D Lindhout; H F Vasen
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

7.  Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.

Authors:  A Lindblom; L Skoog; T I Andersen; S Rotstein; M Nordenskjöld; C Larsson
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

8.  Human breast cancer: frequent p53 allele loss and protein overexpression.

Authors:  S Singh; M Simon; I Meybohm; I Jantke; W Jonat; H Maass; H W Goedde
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

9.  Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms.

Authors:  B Dockhorn-Dworniczak; C Poremba; R Dantcheva; A Stücker; E Brömmelkamp; S Blasius; W Mellin; A Roessner; D W Yandell; W Böcker
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.

Authors:  M Watatani; K Nagayama; Y Imanishi; K Kurooka; T Wada; H Inui; K Hirai; M Ozaki; M Yasutomi
Journal:  Breast Cancer Res Treat       Date:  1993-12       Impact factor: 4.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.